Search
SW033291
go.drugbank.com/drugs/DB32765ExperimentalSW033291 is a small molecule 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor.
GLB-008
go.drugbank.com/drugs/DB32800ExperimentalGLB-008 is a molecular glue degrader targeting VAV1.[L56125, L56126]
XM146-MPA-SN38
go.drugbank.com/drugs/DB32865ExperimentalXM146-MPA-SN38 is a PDL1-targeting polypeptide-MPA-SN38 conjugate.
TN-301
go.drugbank.com/drugs/DB32867ExperimentalTN-301 is a small-molecule histone deacetylase 6 inhibitor.
AZD-8965
go.drugbank.com/drugs/DB32868ExperimentalAZD-8965 is a small molecule inhibitor of ARG-1 and ARG-2.
177Lu-FAP-VG11
go.drugbank.com/drugs/DB33932Experimental177Lu-FAP-VG11 is a small molecule drug. 177Lu-FAP-VG11 is under investigation in clinical trial NCT07808177 (Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein
RCZY690
go.drugbank.com/drugs/DB33931ExperimentalRCZY690 is a small molecule drug. RCZY690 is under investigation in clinical trial NCT07806175 (A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors).
TRTL-729
go.drugbank.com/drugs/DB33923ExperimentalTRTL-729 is a small molecule drug. TRTL-729 is under investigation in clinical trial NCT07811063 (A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729).
Adinazolam
go.drugbank.com/drugs/DB00546ExperimentalAdinazolam (Deracyn®) is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative, and antidepressant properties.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSynonyms: 8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepineMethoxsalen
go.drugbank.com/drugs/DB00553ApprovedInvestigationalIt is a photoactive substance that forms DNA adducts in the presence of ultraviolet A irradiation. … A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia.
Categories: Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP1A2 Inhibitors